ARW
Arrow Electronics, Inc.
ARW has slightly lower modeled downside risk, despite its lower overall score.
NVDA
NVIDIA Corporation
NVDA has the edge over ARW overall, supported by stronger valuation and stronger fundamentals.
ARW Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Healthy | |
| Stable | |
| Healthy |
ARW's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
NVDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
NVDA's revenue, profitability, cash flow and balance sheet are all currently strong.
ARW PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 6.4x | $126 | -37% |
| Current | 10x | $198 | — |
| Fair | 12x | $231 | +17% |
| Expensive | 15x | $296 | +49% |
Historical ranges are pointers, not guarantees.
ARW's PE is in its fair range at 10x.
NVDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $166 | — |
| Current | 21x | $166 | — |
| Cheap | 44x | $345 | +108% |
| Fair | 65x | $511 | +207% |
| Expensive | 93x | $734 | +342% |
Historical ranges are pointers, not guarantees.
NVDA has the edge over ARW in the historical PE scenario, which offers more potential upside but is not a forecast.
ARW Forward outlook
There aren't enough analyst estimates for ARW to show an outlook.
NVDA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for NVDA, but weaker profitability.
ARW Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $19.72 | +118% |
| Q2 2026 | $15.64 | +77% |
| Q1 2026 | $13.97 | +92% |
| Q4 2025 | $10.93 | +50% |
| Q3 2025 | $9.06 | +0.6% |
| Q2 2025 | $8.85 | -17% |
| Q1 2025 | $7.27 | -43% |
| Q4 2024 | $7.29 | -54% |
ARW earned $19.72 per share over the past year, up 118% from the year before.
NVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.77 | +74% |
| Q3 2026 | $7.91 | +125% |
| Q2 2026 | $6.53 | +111% |
| Q1 2026 | $4.90 | +67% |
| Q4 2025 | $4.03 | +59% |
| Q3 2025 | $3.51 | +65% |
| Q2 2025 | $3.10 | +81% |
| Q1 2025 | $2.94 | +147% |
| Q4 2024 | $2.54 | +234% |
NVDA has the edge over ARW on earnings, with more consistent year-over-year improvement.
ARW Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $10.7B | +39% |
| Q2 2026 | $10B | +32% |
| Q1 2026 | $9.5B | +39% |
| Q4 2025 | $8.7B | +20% |
| Q3 2025 | $7.7B | +13% |
| Q2 2025 | $7.6B | +10% |
| Q1 2025 | $6.8B | -1.6% |
| Q4 2024 | $7.3B | -7.2% |
ARW's revenue has grown year over year for six quarters in a row: $10.7B last quarter, up 39% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 4% | +1.7 points |
| Q2 2026 | 3.8% | +1.3 points |
| Q1 2026 | 3.8% | +1.5 points |
| Q4 2025 | 3.4% | +0.7 points |
| Q3 2025 | 2.3% | -0.3 points |
| Q2 2025 | 2.5% | -0.6 points |
| Q1 2025 | 2.3% | -0.4 points |
| Q4 2024 | 2.7% | -1.4 points |
ARW's operating margin was 4% last quarter, up 1.7 points from the same quarter a year ago.
NVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.2B | +106% |
| Q2 2026 | $81.6B | +85% |
| Q1 2026 | $68.1B | +73% |
| Q4 2025 | $57B | +62% |
| Q3 2025 | $46.7B | +56% |
| Q2 2025 | $44.1B | +69% |
| Q1 2025 | $39.3B | +78% |
| Q4 2024 | $35.1B | +94% |
NVDA has the edge over ARW on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +5.4 points |
| Q2 2026 | 66% | +17 points |
| Q1 2026 | 65% | +3.9 points |
| Q4 2025 | 63% | +0.8 points |
| Q3 2025 | 61% | -1.2 points |
| Q2 2025 | 49% | -16 points |
| Q1 2025 | 61% | -0.5 points |
| Q4 2024 | 62% | +4.9 points |
NVDA has the edge over ARW on profitability, with a higher operating margin.
ARW Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$468.3M | -$156.3M |
| Q2 2026 | $297.2M | +$521.7M |
| Q1 2026 | $667.6M | +104% |
| Q4 2025 | $172.6M | -43% |
| Q3 2025 | -$312M | -603% |
| Q2 2025 | -$224.5M | -175% |
| Q1 2025 | $326.7M | -13% |
| Q4 2024 | $303.9M | +16% |
ARW usually generates cash, though not every quarter: the latest was −$468M, but it generated $669M over the past year.
NVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4B | +59% |
| Q2 2026 | $48.6B | +86% |
| Q1 2026 | $34.9B | +124% |
| Q4 2025 | $22.1B | +32% |
| Q3 2025 | $13.5B | -0.3% |
| Q2 2025 | $26.2B | +75% |
| Q1 2025 | $15.6B | +38% |
| Q3 2024 | $13.5B | +113% |
NVDA has the edge over ARW on cash flow, with more consistent year-over-year improvement.
ARW Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.5% | -252K shares |
| 1 year | -1% | -526K shares |
| 3 years | -8.3% | -4.7M shares |
| 5 years | -29% | -21M shares |
| Available history | -38% | -32M shares |
ARW has 52M diluted shares, down 1% from a year ago, with $225M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $99.3M |
| Q2 2026 | $41.9M |
| Q1 2026 | $33.3M |
| Q4 2025 | $50.9M |
| Q3 2025 | $630,000 |
| Q2 2025 | $50.7M |
| Q1 2025 | $59.4M |
| Q4 2024 | $50.8M |
ARW spent $225M buying back its own shares over the past year, up 39% from the year before.
NVDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -106M shares |
| 1 year | -1% | -247M shares |
| 3 years | -2.8% | -705M shares |
| 5 years | -4.1% | -1B shares |
| Available history | -1.8% | -435M shares |
NVDA has 24.3B diluted shares, down 1% from a year ago, with $55.3B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $19.7B |
| Q2 2026 | $19.3B |
| Q1 2026 | $3.8B |
| Q4 2025 | $12.5B |
| Q3 2025 | $9.7B |
| Q2 2025 | $14.1B |
| Q1 2025 | $7.8B |
| Q4 2024 | $11B |
NVDA spent $55.3B buying back its own shares over the past year, up 30% from the year before.
ARW Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.6x | Healthy |
| Q2 2026 | 1.4x | Healthy |
| Q1 2026 | 1.9x | Healthy |
| Q4 2025 | 2.9x | Moderate |
| Q3 2025 | 3.4x | Elevated |
| Q2 2025 | 3.0x | Moderate |
| Q1 2025 | 2.9x | Moderate |
| Q4 2024 | 3.2x | Elevated |
ARW's net debt is about 1.6 years of its operating earnings (EBITDA), down from 3.4 years a year ago.
NVDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
NVDA has the edge over ARW on leverage, with a lower net debt burden relative to earnings.
ARW Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 47.9 | Neutral |
| Stochastic | 20.5 | Neutral |
ARW's weekly RSI is 48 (neutral) and its Stochastic is 21 (neutral).
NVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 18.1 | Oversold |
NVDA's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
ARW PE vs Technology Sector
| Metric | ARW | Sector median | Relative |
|---|---|---|---|
| PE | 10x | 28x | 64% below |
| PE % | 42 | 35 | 7 pts above |
ARW has the edge over NVDA on valuation relative to its sector.
NVDA PE vs Technology Sector
| Metric | NVDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 0 | 35 | 35 pts below |
NVDA is trading at 21x earnings, a 25% discount to the Technology sector's median of 28x.
ARW Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $214.3 | 7.5% below |
| 20 week MA | $212.5 | 6.7% below |
| 50 week MA | $181.1 | 9.4% above |
| 100 week MA | $148.7 | 33% above |
| 200 week MA | $136.5 | 45% above |
ARW has the edge over NVDA on trend strength, trading above more of its moving averages.
NVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $208.9 | 20% below |
| 20 week MA | $212.0 | 22% below |
| 50 week MA | $199.9 | 17% below |
| 100 week MA | $175.1 | 5.1% below |
| 200 week MA | $123.6 | 34% above |
NVDA has fallen below most of its moving averages, though it's still 34% above its 200-week average.
ARW Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $84.5 | $97.1 | +15% |
| 2021 | $97.1 | $130.9 | +35% |
| 2022 | $130.9 | $103.9 | -21% |
| 2023 | $103.9 | $122.3 | +18% |
| 2024 | $122.3 | $114.0 | -6.8% |
| 2025 | $114.0 | $113.4 | -0.5% |
| 2026 YTD | $113.4 | $198.2 | +75% |
ARW has the edge over NVDA on returns for 2026, with the stronger performance.
NVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.92 | $13.0 | +119% |
| 2021 | $13.0 | $29.6 | +128% |
| 2022 | $29.6 | $15.2 | -49% |
| 2023 | $15.2 | $49.5 | +226% |
| 2024 | $49.5 | $137.0 | +177% |
| 2025 | $137.0 | $190.5 | +39% |
| 2026 YTD | $190.5 | $166.2 | -13% |
NVDA's yearly returns have swung widely, from +226% in 2023 to −49% in 2022. It's down 13% so far in 2026.